Goldman Sachs & Co. LLC Acts as Lead Placement Agent for ChronoScale Financing
Goldman Sachs & Co. LLC is serving as the exclusive capital markets advisor and lead placement agent for a new financing round for ChronoScale.
Stocks · News reference
Growth Equity at Goldman Sachs Alternatives led a $280 million Series C funding round for AI-native spend management platform Payhawk, valuing the company at $2 billion.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Goldman Sachs & Co. LLC is serving as the exclusive capital markets advisor and lead placement agent for a new financing round for ChronoScale.
Ducommun Incorporated announced that its CFO will participate in the upcoming Goldman Sachs Industrials & Materials Conference on December 2, 2026.
Goldman Sachs' credit strategy team increased its 2027 global AI project financing forecast by over 80% to $545 billion, citing significant growth in data center and computing power requirements.
Goldman Sachs organized a launch event for its wealth clients featuring Anthropic executives to discuss the upcoming initial public offering.
Payhawk, an AI-native spend management platform, announced the closure of a Series C funding round of $280 million, reaching a $2 billion valuation. Led by Goldman Sachs Growth, the funding will support the development of a financial operating system integrating AI agents, payments, and corporate controls. The company reported positive cash flow in Q3 2026 and maintains 70% of capital from its 2022 funding round.
Ciena, an optical networking company, is positioned to benefit from strong AI infrastructure demand as the next bottleneck in the sector. The stock has declined 40% over three months but is expected to deliver strong Q4 results on December 10. With a book-to-bill ratio significantly greater than 1 and over $10 billion in backlog, Ciena could see its stock price double over the next two years, trading at attractive valuations of 25x forward earnings.